IMMUNITYBIO INC (IBRX) Stock Income Statement
USA - NASDAQ:IBRX - US45256X1037 - Common Stock
2.16 USD
+0.03 (+1.41%)
2.16 USD
0 (0%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 82.56M | 14.74M | 622.00K | 240.00K | 930.00K | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | 77.00K | 81.00K | 656.00K | 750.00K | 3.06M | |||
| Cost Of Goods | 371.00K | 0 | null | null | null | |||
| Gross Profit | 82.18M | 14.74M | null | null | null | |||
| Operating Expenses | 342.93M | 358.93M | 361.99M | 350.86M | 331.21M | |||
| Research and Development | 187.92M | 187.14M | 229.47M | 245.45M | 195.36M | |||
| Selling, General, and Administrative Expenses | 153.00M | 169.78M | 130.52M | 103.51M | 135.86M | |||
| Operating Income | -260.74M | -344.18M | -361.36M | -350.62M | -330.28M | |||
| Interest Income/Expense | -118.33M | -95.65M | -173.66M | -63.77M | -19.26M | |||
| Other Income/Expense | 30.38M | 26.19M | -47.98M | -2.22M | -300.00K | |||
| Non Recurring Items | null | 0 | -886.00K | -680.00K | 0 | |||
| Income Before Taxes | -348.69M | -413.64M | -583.89M | -417.29M | -349.84M | |||
| Income Tax | null | 0 | -40.00K | 30.00K | 10.00K | |||
| Net Income | -348.62M | -413.56M | -583.20M | -416.57M | -346.79M | |||
| EBITDA | -244.95M | -326.63M | -342.85M | -332.36M | -316.04M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.40800000000000003 | -0.5931 | -1.1466 | -1.04 | -0.89 | |||
| Non GAAP EPS | -0.41000000000000003 | -0.6100000000000001 | -1.1300000000000001 | -1.05 | -0.89 | |||
| Statistics | ||||||||
| Gross Profit Margin | 99.55% | 100.00% | N/A | N/A | N/A | |||
| Profit Margin | -422.28% | -2804.77% | -93761.41% | -173570.83% | -37289.25% | |||
| Operating Profit Margin | -315.84% | -2334.23% | -58097.11% | -146091.67% | -35513.98% | |||
All data in USD